Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TILT-123 |
Trade Name | |
Synonyms | igrelimogene litadenorepvec|TILT 123|TILT123 |
Drug Descriptions |
TILT-123 is an oncolytic adenovirus engineered to express cytokines TNF-alpha and IL-2, potentially leading to activation of the immune response, and inhibition of tumor growth when combined with immune checkpoint inhibitors (PMID: 33513935). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C175454 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Avelumab + TILT-123 | Avelumab TILT-123 | 0 | 1 |
Pembrolizumab + TILT-123 | Pembrolizumab TILT-123 | 0 | 2 |
TILT-123 | TILT-123 | 0 | 2 |